Laid - 25 Oct 2024 In Force 22 Nov 2024
These Regulations amend the Medical Certificate of Cause of Death Regulations 2024/492 (“the MCCD Regulations 2024”).
Laid - 21 Oct 2024 In Force Not stated
These Regulations amend the Human Medicines Regulations 2012 (S.I. 2012/1916) (“HMRs”) and the Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031) (“CTRs”). These Regulations make provision for medicinal products that are manufactured in a modular unit, to enable deployment from that site. This is known as modular manufacture …
Laid - 21 Oct 2024 In Force Not stated
These Regulations amend the Medical Devices Regulations 2002 (S.I. 2002/618) (“the 2002 Regulations”) to insert new post-market surveillance requirements. The 2002 Regulations were made under section 2(2) of the European Communities Act 1972 to implement Directives 90/385/EEC, 93/42/EEC and 98/79/EC.
Laid - 3 Sep 2024 In Force 1 Oct 2024
These Regulations amend the Personal Injuries (NHS Charges) (Amounts) Regulations 2015 (S.I. 2015/295) (“the principal Regulations”) which make provision about the charges payable under the scheme for recovery of NHS charges in cases where an injured person who receives a compensation payment in respect of their injury has received NHS …
Laid - 3 Sep 2024 In Force Not stated
These Regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (“the PLPS Regulations”). The PLPS Regulations govern the arrangements in England, under Part 7 of the National Health Service Act 2006 (“the 2006 Act”), for the provision of pharmaceutical and local pharmaceutical services.
Laid - 3 Sep 2024 In Force 1 Oct 2024
These Regulations amend the Ionising Radiation (Medical Exposure) Regulations 2017 (S.I. 2017/1322) (“the 2017 Regulations”). These Regulations are being issued free of charge to those who purchased the Ionising Radiation (Medical Exposure) (Amendment) Regulations 2018 (S.1 2018/121) (“the 2018 Regulations”). The 2018 Regulations made amendments to the 2017 Regulations which …
Laid - 22 Aug 2024 In Force Not stated
This Order prohibits, subject to exceptions, the retail sale, and the supply in circumstances corresponding to retail sale, of medicinal products that consist of or contain a list of gonadotrophin-releasing hormone (“GnRH”) analogues (article 3). It is the second such Order – and, as it applies in Great Britian, it …
Laid - 30 Jul 2024 In Force 1 Sep 2024
These Regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (“the PLPS Regulations”). The PLPS Regulations govern the arrangements in England, under Part 7 of the National Health Service Act 2006 (“the 2006 Act”), for the provision of NHS pharmaceutical and local pharmaceutical services.
Laid - 29 Jul 2024 In Force 1 Jan 2025
The United Kingdom (“UK”) and the European Union (“EU”) agreed to the Windsor Framework in March 2023, including new arrangements relating to the supply of medicines from Great Britain (“GB”) to Northern Ireland (“NI”) (“the Agreement”) to come into effect in January 2025.
Laid - 29 Jul 2024 In Force 2 Dec 2024
These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use.